Talis Biomedical Corp (TLIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -46,934 | -17,420 | -7,374 | -27,474 |
| Depreciation Amortization | 564 | 378 | 185 | 726 |
| Accounts payable and accrued liabilities | 943 | 4,012 | -160 | N/A |
| Other Working Capital | -6,526 | -1,859 | 788 | 640 |
| Other Operating Activity | 1,620 | -2,646 | 979 | 1,782 |
| Operating Cash Flow | $-50,333 | $-17,535 | $-5,582 | $-24,326 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -5,795 | -337 | -119 | -578 |
| Investing Cash Flow | $-5,795 | $-337 | $-119 | $-578 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 13 | 6 | 5 | N/A |
| Other Financing Activity | 124,567 | 111,534 | 0 | 39,613 |
| Financing Cash Flow | $124,580 | $111,540 | $5 | $39,613 |
| Beginning Cash Position | 21,604 | 21,604 | 21,604 | 6,895 |
| End Cash Position | 90,056 | 115,272 | 15,908 | 21,604 |
| Net Cash Flow | $68,452 | $93,668 | $-5,696 | $14,709 |
| Free Cash Flow | ||||
| Operating Cash Flow | -50,333 | -17,535 | -5,582 | -24,326 |
| Capital Expenditure | -5,795 | -337 | -119 | N/A |
| Free Cash Flow | -56,128 | -17,872 | -5,701 | -24,326 |